Target Price | $150.96 |
Price | $123.42 |
Potential | 22.31% |
Number of Estimates | 15 |
15 Analysts have issued a price target Paychex 2026 . The average Paychex target price is $150.96. This is 22.31% higher than the current stock price. The highest price target is $168.00 36.12% , the lowest is $125.83 1.95% . | |
A rating was issued by 21 analysts: 1 Analysts recommend Paychex to buy, 15 to hold and 5 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Paychex stock has an average upside potential 2026 of 22.31% . Most analysts recommend the Paychex stock at Hold. |
17 Analysts have issued a sales forecast Paychex 2026 . The average Paychex sales estimate is $6.7b . This is 19.82% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $6.9b 24.59% , the lowest is $6.4b 14.18% .
This results in the following potential growth metrics:
2025 | $5.6b | 5.56% |
---|---|---|
2026 | $6.7b | 19.82% |
2027 | $7.1b | 6.41% |
2028 | $7.5b | 5.04% |
2029 | $8.3b | 11.14% |
2030 | $8.7b | 5.50% |
11 Analysts have issued an Paychex EBITDA forecast 2026. The average Paychex EBITDA estimate is $3.1b . This is 23.68% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.4b 35.54% , the lowest is $2.9b 13.24% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $2.4b | 1.25% |
---|---|---|
2026 | $3.1b | 29.75% |
2027 | $3.4b | 8.47% |
2028 | $3.6b | 4.52% |
2029 | $4.0b | 12.67% |
2030 | $4.2b | 4.19% |
2025 | 43.43% | 4.08% |
---|---|---|
2026 | 47.03% | 8.28% |
2027 | 47.94% | 1.93% |
2028 | 47.71% | 0.48% |
2029 | 48.37% | 1.38% |
2030 | 47.77% | 1.24% |
18 Paychex Analysts have issued a net profit forecast 2026. The average Paychex net profit estimate is $2.0b . This is 21.01% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.1b 25.39% , the lowest is $1.9b 15.69% .
This results in the following potential growth metrics and future Net Margins:
2025 | $1.7b | 1.96% |
---|---|---|
2026 | $2.0b | 21.01% |
2027 | $2.2b | 8.24% |
2028 | $2.3b | 8.05% |
2029 | $2.6b | 10.68% |
2030 | $2.8b | 6.09% |
2025 | 29.74% | 7.12% |
---|---|---|
2026 | 30.04% | 0.99% |
2027 | 30.56% | 1.73% |
2028 | 31.43% | 2.85% |
2029 | 31.30% | 0.41% |
2030 | 31.48% | 0.58% |
18 Analysts have issued a Paychex forecast for earnings per share. The average Paychex EPS is $5.56 . This is 21.66% higher than earnings per share in the financial year 2025. The highest EPS forecast is $5.76 26.04% , the lowest is $5.32 16.41% .
This results in the following potential growth metrics and future valuations:
2025 | $4.58 | 1.93% |
---|---|---|
2026 | $5.56 | 21.40% |
2027 | $6.02 | 8.27% |
2028 | $6.51 | 8.14% |
2029 | $7.20 | 10.60% |
2030 | $7.64 | 6.11% |
Current | 27.01 | 4.76% |
---|---|---|
2026 | 22.19 | 17.83% |
2027 | 20.50 | 7.62% |
2028 | 18.97 | 7.46% |
2029 | 17.14 | 9.65% |
2030 | 16.15 | 5.78% |
Based on analysts' sales estimates for 2026, the Paychex stock is valued at an EV/Sales of 7.15 and an P/S ratio of 6.65 .
This results in the following potential growth metrics and future valuations:
Current | 8.57 | 3.49% |
---|---|---|
2026 | 7.15 | 16.59% |
2027 | 6.72 | 6.03% |
2028 | 6.40 | 4.80% |
2029 | 5.75 | 10.02% |
2030 | 5.45 | 5.21% |
Current | 7.97 | 11.54% |
---|---|---|
2026 | 6.65 | 16.54% |
2027 | 6.25 | 6.02% |
2028 | 5.95 | 4.80% |
2029 | 5.36 | 10.02% |
2030 | 5.08 | 5.21% |
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 01 2025 |
BMO Capital |
Market Perform
➜
Market Perform
|
Unchanged | Oct 01 2025 |
Stifel |
Hold
➜
Hold
|
Unchanged | Sep 22 2025 |
UBS |
Neutral
➜
Neutral
|
Unchanged | Sep 17 2025 |
Citigroup |
Neutral
➜
Neutral
|
Unchanged | Aug 21 2025 |
JP Morgan |
Underweight
➜
Underweight
|
Unchanged | Aug 14 2025 |
BMO Capital |
➜
Market Perform
|
Initiated | Jul 10 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 01 2025 |
Unchanged
BMO Capital:
Market Perform
➜
Market Perform
|
Oct 01 2025 |
Unchanged
Stifel:
Hold
➜
Hold
|
Sep 22 2025 |
Unchanged
UBS:
Neutral
➜
Neutral
|
Sep 17 2025 |
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Aug 21 2025 |
Unchanged
JP Morgan:
Underweight
➜
Underweight
|
Aug 14 2025 |
Initiated
BMO Capital:
➜
Market Perform
|
Jul 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.